跳至主要内容
临床试验/IRCT2013081914404N1
IRCT2013081914404N1已完成2 期

Comparison of 0.125 and 0.250 mg of Naltrexone with Placebo in Decreasing Withdrawal Syndrome in Patients with Opium Addiction Referring to Addiction Treatment Clinic of Imam Reza (p) Hospital: A Clinical Trial

Vice Chancellor for Research of Mashhad University of Medical Sciences0 个研究点目标入组 63 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
63

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
Male

入选标准

  • Inclusion Criteria: Male patients who choose outpatient protocol for detoxification of opioids including opium, heroin, crack and tramadol ;filling the consent

排除标准

  • Cancer; Known pain syndrome; Diabetes

研究者

发起方
Vice Chancellor for Research of Mashhad University of Medical Sciences

相似试验